Howard Malcolm Prentice

Title: The Innovative Contributions of Howard Malcolm Prentice

Introduction

Howard Malcolm Prentice is a notable inventor based in Boca Raton, Florida. He has made significant contributions to the field of medical science, particularly in the treatment of ischemic stroke and retinopathy. With a total of seven patents to his name, Prentice's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

Prentice's latest patents include groundbreaking treatments for ischemic stroke. One of his notable inventions involves the use of Granulocyte colony-stimulating factor (G-CSF), which acts as a stem cell enhancer and facilitator. Additionally, he has developed DETC-MeSO, a glutamate receptor partial antagonist and anti-excitotoxicity agent, along with sulindac, a potent anti-oxidant and anti-inflammatory agent. Each of these agents can protect brain tissue exposed to cerebral ischemia/reperfusion injury and minimize the size of infarcts that develop as a result of such injuries. When administered in combination, these agents are effective at protecting brain tissue and minimizing infarct size at much lower concentrations compared to using a single agent. Furthermore, Prentice has also patented a method for preventing degeneration of photoreceptor cells in the eye of a mammalian subject, which involves administering a pharmaceutical composition comprising a sulindac agent.

Career Highlights

Throughout his career, Prentice has worked with various organizations, including Chs Pharma, Inc. and Florida Atlantic University Research Corporation. His work in these institutions has allowed him to further his research and develop innovative solutions to pressing medical issues.

Collaborations

Prentice has collaborated with esteemed colleagues such as Jang-Yen Wu and Janet C Blanks. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Howard Malcolm Prentice's innovative contributions to medical science, particularly in the treatment of ischemic stroke and retinopathy, showcase his dedication to improving patient outcomes. His patents reflect a commitment to advancing healthcare through scientific research and innovation.